Insider Transactions in Q1 2024 at Ocuphire Pharma, Inc. (OCUP)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2024
|
Joseph K Schachle Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$4,000
$2.05 P/Share
|
|
Mar 21
2024
|
Nirav S. Jhaveri Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+6.25%
|
$20,000
$2.1 P/Share
|
|
Mar 18
2024
|
George Magrath Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+5.56%
|
$25,000
$1.96 P/Share
|
|
Feb 12
2024
|
Ashwath Jayagopal Chief Scientific & Dev. Ofc. |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
|
Feb 12
2024
|
Nirav S. Jhaveri Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+50.0%
|
-
|
|
Jan 18
2024
|
Rabourn Amy Zaremba SVP of Finance |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+32.61%
|
-
|
|
Jan 18
2024
|
Bernhard Hoffmann SVP of Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+10.95%
|
-
|
|
Jan 10
2024
|
Bernhard Hoffmann SVP of Corp. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,031
-2.75%
|
$12,093
$3.27 P/Share
|
|
Jan 10
2024
|
Ronil A. Patel Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,282
-1.39%
|
$3,846
$3.27 P/Share
|
|
Jan 10
2024
|
Rabourn Amy Zaremba SVP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-8.47%
|
$11,850
$3.27 P/Share
|
|
Jan 01
2024
|
James S J Manuso |
BUY
Grant, award, or other acquisition
|
Direct |
22,090
+19.55%
|
-
|
|
Jan 01
2024
|
Jay Pepose |
BUY
Grant, award, or other acquisition
|
Direct |
14,964
+12.24%
|
-
|
|
Jan 01
2024
|
Richard J Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
24,762
+11.12%
|
-
|
|
Jan 01
2024
|
Susan Benton |
BUY
Grant, award, or other acquisition
|
Direct |
19,418
+16.41%
|
-
|